Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
OPTN OptiNose
- 6.000
- +0.380+6.76%
Close Feb 14 16:00 ET
60.33MMarket Cap-1.38P/E (TTM)
6.170High5.460Low23.56KVolume5.620Open5.620Pre Close139.34KTurnover0.44%Turnover RatioLossP/E (Static)10.06MShares31.50052wk High-1.47P/B32.15MFloat Cap4.81552wk Low--Dividend TTM5.36MShs Float450.000Historical High--Div YieldTTM12.63%Amplitude4.815Historical Low5.913Avg Price1Lot Size
About OptiNose Company
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Company Profile
SymbolOPTN
Company NameOptiNose
Listing DateOct 13, 2017
Issue Price16.00
Founded2000
CEODr. Ramy A. Mahmoud, M.D.
MarketNASDAQ
Employees132
Fiscal Year Ends12-31
Address777 Township Line Road,Suite 300
CityYardley
ProvincePennsylvania
CountryUnited States of America
Zip Code19067
Phone1-267-364-3500
Websitehttp://www.optinose.com
Company Executives
- Name
- Position
- Salary
- Dr. Ramy A. Mahmoud, M.D.
- Chief Executive Officer and Director
- 2.41M
- Anthony J. Krick
- Vice President, Finance and Chief Accounting Officer
- --
- P. Terence Kohler, Jr
- Chief Financial Officer
- --
- Paul Spence, Jr
- Chief Commercial Officer
- 664.02K
- Michael F. Marino, III,
- Chief Legal Officer and Corporate Secretary
- 1.32M
- R. John Fletcher
- Chairman of the Board
- 120.22K
- Tomas J. Heyman
- Independent Director
- 96.88K
- Kyle Dempsey
- Independent Director
- 90.92K
- Dr. Eric Bednarski
- Independent Director
- 88.42K
- Wilhelmus C. M. Groenhuysen
- Independent Director
- 100.92K
- Sandra L. Helton
- Independent Director
- 103.42K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.